Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$23.28 USD
-0.11 (-0.47%)
Updated Jul 23, 2024 04:00 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.91 |
EPS Last Quarter | -0.85 |
Last EPS Surprise | 11.46% |
ABR | 1.14 |
Earnings ESP
|
4.40% |
---|---|
Current Year | -3.49 |
Next Year | -2.89 |
EPS (TTM) | -3.22 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 4.96M | 38.46M | 105.08M |
# of Estimates | NA | 2 | 5 | 5 |
High Estimate | NA | 6.00M | 101.00M | 145.00M |
Low Estimate | NA | 3.92M | 6.59M | 73.90M |
Year ago Sales | 0.00M | 0.00M | NA | 38.46M |
Year over Year Growth Est. | NA | NA | NA | 173.19% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.91 | -1.04 | -3.49 | -2.89 |
# of Estimates | 7 | 5 | 7 | 7 |
Most Recent Consensus | -0.96 | -0.95 | -3.71 | -3.40 |
High Estimate | -0.86 | -0.95 | -2.94 | -1.07 |
Low Estimate | -0.97 | -1.10 | -3.98 | -3.69 |
Year ago EPS | -0.64 | -0.73 | -2.98 | -3.49 |
Year over Year Growth Est. | -42.19% | -42.47% | -17.11% | 17.07% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.91 | -1.04 | -3.49 | -2.89 |
7 Days Ago | -0.91 | -1.04 | -3.49 | -2.89 |
30 Days Ago | -0.92 | -1.05 | -3.56 | -2.95 |
60 Days Ago | -0.92 | -1.05 | -3.57 | -2.96 |
90 Days Ago | -0.99 | -1.02 | -3.70 | -2.86 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.87 | -1.08 | -3.08 | -3.01 |
Zacks Consensus Estimate | -0.91 | -1.04 | -3.49 | -2.89 |
Earnings ESP | 4.40% | -3.65% | 11.78% | -3.98% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.85 | -1.00 | -0.73 | -0.64 | NA |
Estimate | -0.96 | -0.99 | -0.80 | -0.73 | NA |
Difference | 0.11 | -0.01 | 0.07 | 0.09 | 0.07 |
Surprise | 11.46% | -1.01% | 8.75% | 12.33% | 7.88% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more